
Corporate
Compass Pathways Wins FDA Green Light for PTSD Trial as Psilocybin Pioneer Prepares for 2026 Launch
Jan 7
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for COMPASS Pathways.
Nov 4, 2025
Jul 31, 2025
May 8, 2025
Feb 27, 2025
Oct 31, 2024
Aug 1, 2024
Aug 11, 2021
May 13, 2021
Mar 9, 2021
Nov 12, 2020